Spinal cord injury (SCI) is a traumatic lesion that causes disability with temporary or
permanent sensory and/or motor deficits. The pharmacological approach still in use for the …

Cell transplantation, as a therapeutic intervention for spinal cord injury (SCI), has been
extensively studied by researchers in recent years. A number of different kinds of stem cells …

Background Umbilical cord mesenchymal stem cells (UCMSCs) have a considerable
advantage and potential in treating for central nervous system diseases and have become a …

In a phase I/IIa open‐label and nonrandomized controlled clinical trial, we sought to assess
the safety and neurological effects of human neural stem/progenitor cells (hNSPCs) …

More than 1 million people in the United States live with a spinal cord injury (SCI). Despite
medical advances, many patients with SCIs still experience substantial neurological …

Spinal cord injury (SCI) is the destruction of spinal cord motor and sensory resulted from an
attack on the spinal cord, which can cause significant physiological damage. The …

Nearly 1.5 million people in the US live with a spinal cord injury (SCI). The cost to the
healthcare system is estimated at over $10 billion annually likely because over 65% of SCIs …

Peripheral neuropathic pain typically results from trauma-induced nociceptive neuron
hyperexcitability and their spontaneous ectopic activity. This pain persists until the trauma …

The role of regenerative medicine in clinical therapies is becoming increasingly vital. Under
specific conditions, mesenchymal stem cells (MSCs) are capable of differentiating into …

Myelin-associated inhibitors (MAIs) and chondroitin sulfate proteoglycans (CSPGs) are
major contributors to axon growth inhibition following spinal cord injury and limit functional …